Previous studies have reported that inhibition of RhoA/ROCK signaling significantly reduced anti-dsDNA antibody levels in lupus-prone NZB/NZW F1 mice, effectively alleviating renal damage and reducing mortality [21]. The gene discussed is RHOA; the disease is systemic lupus erythematosus.